1
Views
2
CrossRef citations to date
0
Altmetric
Original Article

A pitfall in the evaluation of medical therapy for occlusive arterial disease using the xenon wash-out technique

, &
Pages 229-231 | Received 20 Aug 1986, Accepted 06 Nov 1986, Published online: 17 Mar 2010

References

  • Carlson L A, Erikson I. Femoral-artery infusion of prostaglandin E, in severe peripheral vascular disease. Lancet 1973; i: 155–6
  • Olsson A G, Nielsson E. The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral arterial disease. Prostaglandines Med 1981; 6: 329–39
  • Belch J FF, McArdle B, Pollock J., et al. Epopros-tenol (prostacyclin) and severe arterial disease. A double blind trial. Lancet 1983; i: 315–7
  • Tyler H M, Saxton CAPD, Parry M J. Administration to man of UK 37, 24801, a selective inhibitor of tromboxane synthetase. Lancet 1981; i: 629–32
  • Jelnes R, Bülow J. Evaluation of a method of determination of the subcutaneous blood flow in the forefoot continuously over 24 hours. Scand J Clin Lab Invest 1984; 44: 85–90
  • Jelnes R, Bülow J, Tønnesen K H. Subcutaneous adipose tissue blood flow in the forefoot during 24 hours. Labelling pattern and reproducibility. Scand J Clin Lab Invest 1987; 47: 223–7
  • Jelnes R, Rasmussen L B, Eickhoff J H. Direct determination of the tissue-to-blood partition coefficient for xenon in human adipose tissue. Scand J Clin Lab Invest 1984; 44: 643–7
  • Randall M J, Parry M J, Hawkeswood E, et al. UK-37248, a novel, selective tromboxane synthetase inhibitor with platelet antiaggregatory and antithrombotic activity. Thromb Res 1981; 23: 145–62
  • Jelnes R, Astrup A, Bülow J. The double isotope technique for in vivo determination of the tissue-to-blood partition coefficient for xenon in human subcutaneous tissue—an evaluation. Scand J Clin Lab Invest 1985; 45: 565–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.